EVENTS · EBS
PEERS
EARNINGS
Emergent BioSolutions Inc. is a life sciences company focused on preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats. Its current business centers on medical countermeasures and specialty products, including public health protection tools used by government agencies, healthcare providers, and other institutional customers. The company’s portfolio includes commercial products, medical countermeasure products, and services, with an emphasis on areas such as opioid overdose reversal, smallpox and anthrax preparedness, and contract development and manufacturing support. Emergent BioSolutions plays a specialized role in the healthcare and biodefense markets by supplying products and services designed to support emergency readiness and public health response across the United States and international markets.
Emergent BioSolutions Receives Modification for Up to $22.3 Million BioThrax Supply to U.S. Military
| Series | 1W | 1M |
|---|---|---|
| EBS | −16.8% | −15.1% |
| Peers | +2.1% | +8.2% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 4 | 10 |
| QUARTER | EPS EST | EPS ACTUAL | EPS SURPRISE | REACTION |
|---|---|---|---|---|
| Q3 FY2026 | −0.45 | −0.36 | +20.00% | — |
| Series | 1W | 1M |
|---|---|---|
| EBS | −16.8% | −15.1% |
| Peers | +2.1% | +8.2% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 4 | 10 |
